NYSportsMed Unveils ?Game-Changing? Osteoarthritis Treatment For Athletes

NYSportsMed Unveils “Game-Changing” Osteoarthritis Treatment For Athletes










New York, NY (PRWEB) December 30, 2011

NY SportsMed, a leading provider of sports medicine and physical therapy services in the metropolitan New York area, is pleased to announce that they are exclusive providers in the eastern United States of Regenokine ® Therapy. This “game-changing” treatment, previously only available in Germany, is intended to improve the pain and discomfort caused by osteoarthritis and other inflammatory joint conditions.

Regenokine ® Therapy, developed by Dr. Peter Wehling of Dusseldorf, Germany, where the procedure is known as Orthokine, is a patented, non-surgical procedure that treats mild to severe cases of osteoarthritis and joint inflammation.  The Regenokine ®treatment relies on the body’s own healing capabilities to stop inflammation, while relieving pain and stiffness..  It can also improve symptoms resulting from a degeneration of cartilage in the joints and halt or slow the progression of the condition. Regenokine Therapy produces the first truly personalized treatment for osteoarthritis.

To date, an estimated 60,000 patients have undergone Regenokine ® Therapy in Germany to treat inflammatory joint conditions such as osteoarthritis. The treatment requires only a single extraction of the patient’s own blood and a series of injections to re-introduce an enhanced serum into the affected area. The innovative treatment has recently received notable press in the “New York Post” and “LA Times”, both sources mention that professional athletes of the NBA, MLB, and PGA are seeking out this treatment.

Dr. Edward Capla and Dr. Michael Neely have been instrumental in launching the state-of-the-art Regenokine ® treatment program in the eastern portion of the United States.  Dr. Michael Neely of NY SportsMed in Manhattan has partnered with Dr. Capla to offer the Regenokine® procedure within his practice.

“I have observed remarkable results in my patients that have received Regenokine® Therapy,” explains Dr. Capla. “This cutting-edge treatment is now the “go-to” choice for athletes looking for relief from osteoarthritis pain and inflammation to improve performance.” Drs. Capla and Neely are not the only one who has observed these positive results. Dr. Wehling has cited clinical studies supporting the effectiveness of his treatment and claims that a majority of those undergoing Regenokine® treatment see significant improvement in their symptoms.

Dr. Neely explains that the theory behind the Regenokine® procedure is that it is the inflammation triggered by osteoarthritis that causes the pain and discomfort associated with the condition. By treating the associated inflammation, symptoms are reduced. Some patients notice almost immediate improvement, while in others it can take several weeks to feel the full effect of the treatment. The procedure can be done on the ankle, knee, hip, shoulder, elbow, wrist, finger, toe and spine, and is extremely well tolerated since it only utilises components found in a patient’s own blood. Effects can last up to four years and the procedure can be repeated every two to four years, as necessary.

“Millions of people suffer from osteoarthritis and athletes are especially prone to this condition because of repeated wear and tear,” explains Dr. Neely. “We haven’t seen anything as effective as Regenokine® in treating our athletic patients in a long time. I think this treatment will change the lives of many people by decreasing pain and increasing their ability to exercise for heart health and perform the activities that they enjoy doing. Our goal is to help get athletes back in the game and Regenokine® can do that in ways unlike any we’ve ever seen before.”

Regenokine® Therapy, also known internationally as Orthokine, is available at NY SportsMed in Manhattan. For more information about this “game-changing” treatment for osteoarthritis and inflammatory joint conditions, or to schedule an appointment, contact NY SportsMed at 212-750-1110 or visit their website at http://nysportsmed.com.

###





















Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







One Response to “NYSportsMed Unveils ?Game-Changing? Osteoarthritis Treatment For Athletes”

  1. Lopez Daniel says:

    I can see that you are putting a lots of efforts into your blog. Keep posting the good work.Some really helpful information in there. Bookmarked. Nice to see your site. Thanks!

Leave a Response